The antiproliferative action of the three NK-1R antagonists mentioned above is related to the affinity for NK-1R: the most potent antagonist against GAMG glioma cells was L-733,060 followed by aprepitant and L-732,138 [29,32]. The gene discussed is TACR1; the disease is glioma.